Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy - Wikidata - wikimedia - TriplyDB

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

http://www.wikidata.org/entity/Q33748541

about

Management of Membranous Nephropathy in Western Countries Rituximab use in adult primary glomerulopathy: where is the evidence?Triggers, bullets and targets, puzzle of membranous nephropathy.Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy A diagnostic approach for defining idiopathic remitting diabetes: a retrospective cohort study.Membranous nephropathy: from models to man A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy Idiopathic membranous nephropathy: an autoimmune disease.American Society of Nephrology quiz and questionnaire 2014: glomerular diseases Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Pharmacological treatment of primary membranous nephropathy in 2016.Rituximab in idiopathic membranous nephropathy.Membranous Nephropathy: Quantifying Remission Duration on Outcome.Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.Treatment of idiopathic membranous nephropathy.Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.Factors affecting the long-term outcomes of idiopathic membranous nephropathy.Analysis of the prognostic risk factors of idiopathic membranous nephropathy using a new surrogate end-point.Treatment pattern in patients with idiopathic membranous nephropathy-practices in Sweden at the start of the millennium Transplant outcomes in patients with idiopathic membranous nephropathy.Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study.Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy Membranous nephropathy: Treatment outline and risk stratification S-Fas urinary excretion helps to predict the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population.Treatment with rituximab in idiopathic membranous nephropathy.HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.Management of idiopathic membranous nephropathy.Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.

P2860

Q26740477-EE7C02F4-D663-4BAB-B9BA-6A9C701CB089 Q28075564-159E5512-DAEA-4A45-BB4D-25D87B9424EC Q33355637-EACD5886-A0C9-412B-979B-A0011EB77A9A Q33660542-4AC3C35B-FCEC-4131-86C1-68533493FFDB Q33783221-8AA6A5CD-CE2C-4377-A373-08C9E2CBE016 Q33872569-E0E84AA9-C0C0-475E-B956-8C772741FC07 Q33932604-4783EDBD-10EA-41AA-B147-C7D4ED839103 Q34338687-4C1EA581-0AA8-480C-A716-50CE7C9C1B36 Q34362660-22174810-138C-4632-9ED1-AC1A811FF6F4 Q35142743-ADAD6246-142F-489B-832A-D241F4E33206 Q35165475-A2F62B20-BE98-4E0E-BA54-D43D68AFC1B8 Q35278674-ECA5133B-1A87-45F2-BF98-A9D8D2E48067 Q35433416-C425BAA6-376A-40ED-814C-4A2E5585209C Q35664611-5F73EADF-375E-46F1-95D2-A90BAF3AD722 Q35745565-B55C3281-493B-4D2C-B79E-C61C2DF2A9B7 Q35791799-38010491-376B-4EDF-A19A-463B3DF14986 Q36088887-6C3F0A4B-320C-4C53-B57F-869F4D166731 Q36106413-4538DAB1-0751-44B4-AF4C-61502B230849 Q36109197-36E7BDE8-6492-41D6-8E0A-5682B4BCF06F Q36167127-FD1544AF-FA19-44F8-95D6-D4781A0C5AD6 Q36265388-E59F94C8-3BFF-4183-AE09-73AFA9DCC826 Q36280345-FD9FDFF9-499D-47D0-B304-2900AA61EA4B Q36296621-DBA2FBBF-6355-4911-905A-9C81E4A62741 Q36314982-50781F71-9E61-492C-9323-F508A38CCAE8 Q36324367-497313FA-5D8D-4870-9706-563237E9D8E9 Q36524378-F17F7170-5065-4F06-8E6D-2F4FD065FE66 Q36689205-CB804963-B907-481A-BA00-FD51936D4796 Q36691977-23A22C76-4EDF-42BD-AA4B-63788B8E6E0A Q36741001-B9F07FFB-4EB8-4CFE-A6AD-339EA4629DFC Q36872799-9AE52D1E-07AD-47D0-BC6D-F01CD9B1D15B Q36970147-AA856218-FE32-4118-B36E-AD74E7667103 Q37220474-1A617B52-0E2A-4023-9659-23D0A77BB15C Q37411651-0E043680-8AD5-4DFE-BB65-2396AE548759 Q37475696-1D7F3EB8-B3DF-4477-A250-E20658BF89C2 Q37476106-46B46AFA-11DC-40B3-8526-74B3DFADDE6A Q37511019-FB4558FE-51DD-4975-B52A-B22E7C95AA15 Q37553082-FB5DD23A-49E2-4716-B99C-AB9A4BB8826A Q37665145-E8E17396-F502-4C97-8E87-647581F649AD Q37779802-21465CAB-BC24-4B18-989B-9195433FF0D9 Q37871572-F07EFF91-88E0-41A4-A667-61EB1C059F77

P2860

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

http://www.wikidata.org/entity/Q33748541

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@ast

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@en

type

label

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@ast

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@en

prefLabel

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@ast

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@en

P1433

Q33748541-A6040C24-2724-4E70-B615-6BF83DC0B7DC

P1476

Q33748541-E609771F-8B42-4AC1-B1AE-90B5DC59DD4B

P2093

Q33748541-06501130-9126-4BE9-A17D-DA2CCD1D2C85

Q33748541-0D4D6AA3-D46A-4CB7-8016-98A7BF89D104

Q33748541-277C1AF8-162A-4849-AF36-F80B1254E8E0

Q33748541-2EB7E257-893D-41BE-81FC-11A6BDA98A57

Q33748541-34D801FA-35AF-4846-8135-32CAA51969F2

Q33748541-3FD17BC9-7C74-49C2-83C2-90AF99C845D8

Q33748541-4E02E89E-8358-466A-90BA-F668F9BBD734

Q33748541-4FF3303B-CEC3-4146-B91D-F5F59E300685

Q33748541-53AF6026-7295-4232-89BE-1564F40B1551

Q33748541-6062192E-C269-41A9-A218-3BE332776ABA

P2860

Q33748541-13262F17-76CE-4E43-8218-951B348C5FE5

Q33748541-1F594128-2D15-4669-90E4-C116B016B2C8

Q33748541-25F9A775-39A6-4015-8AF0-97F36B7A23B7

Q33748541-2BDEED92-34B9-45A0-A631-D3D66E3B47D5

Q33748541-2E0732DD-FC75-4891-9774-7718C3E09A22

Q33748541-38609C06-ED45-4F1C-90CF-D2C52F367A64

Q33748541-772D5FD7-48EB-48B2-81BA-C2EDB65AD191

Q33748541-7A5ADEA9-86A6-4661-B2FC-62D7572E04C4

Q33748541-97D87FD3-5AF1-4C06-88AC-09C1411A878C

Q33748541-D568103C-FFF7-4EFC-8792-0F3A929595C7

P304

Q33748541-EF688672-55D7-49F8-9602-EDC38B499476

P31

Q33748541-33B48F52-D305-4045-AB8D-1A55E3C84F2E

P356

Q33748541-73F4742C-47AF-438B-BCAD-0AE79B9A3243

P433

Q33748541-487A3407-D223-45BA-9113-A25A1BBB70E8

P478

Q33748541-2547CAE3-9879-405A-A36E-4AC77E72E908

P577

Q33748541-868C480C-AAD7-4E32-B65C-F8F2C93BAAAB

P5875

Q33748541-26081C8D-C899-4290-97DF-DD31CFACDDD3

P698

Q33748541-93B9E1A1-263D-4B33-B094-09E3D0A99FCC

P932

Q33748541-BA6C5152-F958-4AEF-A1B2-1CB6600C9BBD

P356

P1433

Journal of the American Society of Nephrology

P1476

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

@en

P2093

Adelardo Covarsí

http://www.w3.org/2001/XMLSchema#string

Agustín Carreño

http://www.w3.org/2001/XMLSchema#string

Ana Vigil

http://www.w3.org/2001/XMLSchema#string

Aniana Oliet

http://www.w3.org/2001/XMLSchema#string

Carmen Bernis

http://www.w3.org/2001/XMLSchema#string

Carmen Martín

http://www.w3.org/2001/XMLSchema#string

Dolores Lorenzo

http://www.w3.org/2001/XMLSchema#string

Elena Gutiérrez

http://www.w3.org/2001/XMLSchema#string

Francisco Ariza

http://www.w3.org/2001/XMLSchema#string

Francisco Fernández-Vega

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

Idiopathic membranous glomerulonephritis.

Management of membranous nephropathy: when and what for treatment.

The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.

The natural history of the non-nephrotic membranous nephropathy patient.

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients.

Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.

P304

697-704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2009080861

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41173683

http://www.w3.org/2001/XMLSchema#string

P698

20110379

http://www.w3.org/2001/XMLSchema#string

P932

2844306

http://www.w3.org/2001/XMLSchema#string